ZA747287B - Diagnostic agent of for the control of the coagulability of blood, process for its manufacture and stabilizer for this agent - Google Patents

Diagnostic agent of for the control of the coagulability of blood, process for its manufacture and stabilizer for this agent

Info

Publication number
ZA747287B
ZA747287B ZA00747287A ZA747287A ZA747287B ZA 747287 B ZA747287 B ZA 747287B ZA 00747287 A ZA00747287 A ZA 00747287A ZA 747287 A ZA747287 A ZA 747287A ZA 747287 B ZA747287 B ZA 747287B
Authority
ZA
South Africa
Prior art keywords
agent
coagulability
stabilizer
blood
manufacture
Prior art date
Application number
ZA00747287A
Other languages
English (en)
Inventor
H Schwinn
H Trobisch
Original Assignee
Marburg Lahn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19732356493 external-priority patent/DE2356493C3/de
Application filed by Marburg Lahn filed Critical Marburg Lahn
Publication of ZA747287B publication Critical patent/ZA747287B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/7452—Thrombomodulin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA00747287A 1973-11-13 1974-11-13 Diagnostic agent of for the control of the coagulability of blood, process for its manufacture and stabilizer for this agent ZA747287B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732356493 DE2356493C3 (de) 1973-11-13 Verfahren zur Herstellung eines Thromboplastins und diagnostisches Mittel zur Kontrolle der Gerinnungsfähigkeit des Blutes

Publications (1)

Publication Number Publication Date
ZA747287B true ZA747287B (en) 1975-11-26

Family

ID=5897898

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00747287A ZA747287B (en) 1973-11-13 1974-11-13 Diagnostic agent of for the control of the coagulability of blood, process for its manufacture and stabilizer for this agent

Country Status (20)

Country Link
US (1) US3983004A (xx)
JP (1) JPS5843080B2 (xx)
AT (1) AT338981B (xx)
AU (1) AU497109B2 (xx)
BE (1) BE822134A (xx)
BR (1) BR7409498A (xx)
CA (1) CA1043702A (xx)
CH (1) CH611426A5 (xx)
DK (1) DK138256C (xx)
ES (1) ES431736A1 (xx)
FI (1) FI327274A (xx)
FR (1) FR2251002B1 (xx)
GB (1) GB1490209A (xx)
IE (1) IE40114B1 (xx)
IT (1) IT1025596B (xx)
LU (1) LU71264A1 (xx)
NL (1) NL7414604A (xx)
NO (1) NO744074L (xx)
SE (1) SE7414232L (xx)
ZA (1) ZA747287B (xx)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2525804B2 (de) * 1975-06-10 1980-04-03 Behringwerke Ag, 3550 Marburg Stabiler Clumping-Faktor, Verwendung desselben zum Nachweis von Fibrinogen- und Fibrinspaltprodukten und Herstellung desselben
US4116635A (en) * 1977-03-14 1978-09-26 Jaeger Mark A General purpose in vitro anticoagulant
DE2757992A1 (de) * 1977-12-24 1979-06-28 Boehringer Mannheim Gmbh Verfahren zur prothrombin-bestimmung
DE2836362A1 (de) * 1978-08-19 1980-03-06 Behringwerke Ag Diagnostisches mittel
US4276383A (en) * 1979-08-02 1981-06-30 The United States Of America As Represented By The Department Of Health, Education & Welfare Clot lysing timer
DE3150596A1 (de) * 1981-12-21 1983-06-30 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung von gewebsthromboplastin
DE3413311A1 (de) * 1984-04-09 1985-10-17 Behringwerke Ag, 3550 Marburg Reagenz zur bestimmung der thromboplastinzeit
NO852655L (no) * 1985-06-05 1986-12-08 Bio Data Corp Fremgangsmaate ved fremstilling av koaguleringsreagens for blodplasma i mikrokonsentrert tablettform.
US4755461A (en) * 1986-04-17 1988-07-05 Bio/Data Corporation Tableted blood plasma microconcentrated thromboplastin coagulation reagent
US5270451A (en) * 1988-11-23 1993-12-14 Baxter Diagnostics Inc. Extraction method for preparing thromboplastin reagents
US5281528A (en) * 1989-12-18 1994-01-25 Warner-Lambert Company Process for purified thromboplastin for ultra-pure thrombin preparation
US6261792B1 (en) 1990-12-07 2001-07-17 The Liposome Company, Inc. Lipid-dependent diagnostic assays
JP3180824B2 (ja) * 1991-08-30 2001-06-25 シスメックス株式会社 血液凝固試薬
US5780255A (en) * 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
ATE313068T1 (de) 1998-10-07 2005-12-15 Trinity Biotech Mfg Ltd Thromboplastin-reagenzien und verfahren zur herstellung und anwendung derselben
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
WO2006088741A2 (en) * 2005-02-16 2006-08-24 The Board Of Trustees Of The University Of Illinois Procoagulants based on metal-chelating lipids
ATE505488T1 (de) * 2005-03-04 2011-04-15 Univ Illinois Modulator von coagulationskaskaden und fibrinolytischen kaskaden
WO2009046194A2 (en) * 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
US20100297257A1 (en) * 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
US20210405072A1 (en) * 2018-09-25 2021-12-30 Sekisui Medical Co., Ltd. Method for measuring blood coagulation time

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2687980A (en) * 1948-09-15 1954-08-31 Ernest W Blanchard Thromboplastin product and method for preparing same
US2847347A (en) * 1954-05-27 1958-08-12 Ortho Pharmacentical Corp Preparation of improved thromboplastin
US3522148A (en) * 1965-08-13 1970-07-28 Dade Reagents Inc Stabilized thromboplastin preparation
BE787961A (fr) * 1971-08-24 1973-02-26 Behringwerke Ag Procede d'isolement d'une matiere thromboplastique et medicament contenant ladite matiere

Also Published As

Publication number Publication date
DK588174A (xx) 1975-07-14
IE40114L (en) 1975-05-13
DE2356493B2 (de) 1976-09-16
AT338981B (de) 1977-09-26
US3983004A (en) 1976-09-28
ES431736A1 (es) 1977-05-16
FR2251002B1 (xx) 1978-06-16
JPS5085393A (xx) 1975-07-09
DK138256B (da) 1978-08-07
JPS5843080B2 (ja) 1983-09-24
IT1025596B (it) 1978-08-30
BE822134A (fr) 1975-05-13
SE7414232L (xx) 1975-05-14
DE2356493A1 (de) 1975-05-15
AU7522874A (en) 1976-05-13
DK138256C (da) 1979-01-22
IE40114B1 (en) 1979-03-14
NO744074L (xx) 1975-06-09
ATA903974A (de) 1977-01-15
FR2251002A1 (xx) 1975-06-06
LU71264A1 (xx) 1976-09-06
NL7414604A (nl) 1975-05-15
AU497109B2 (en) 1978-11-30
FI327274A (xx) 1975-05-14
CH611426A5 (xx) 1979-05-31
CA1043702A (en) 1978-12-05
BR7409498A (pt) 1976-05-25
GB1490209A (en) 1977-10-26

Similar Documents

Publication Publication Date Title
ZA747287B (en) Diagnostic agent of for the control of the coagulability of blood, process for its manufacture and stabilizer for this agent
RO69615A (ro) Procedeu pentru prepararea unor 2,4,6-triiod-izo-ftaloilamide
IL43495A0 (en) Process for the manufacture of insulin,analogs and derivatives thereof
EP0018976A4 (fr) Hydrolysat de proteines a usage medical et son procede d'utilisation.
NO740841L (no) Fremgangsmåte for fremstilling av 1-beta-D-ribofuranosyl-1, 2, 4-triazol-3-karboksamid.
CA1016535A (en) .delta. 8,9 steroids of the pregnane series
GB1536875A (en) Process for the manufacture of oestrene-3,17-dione derivatives
NO741929L (no) Analogifremgangsmåte til fremstilling av 17beta-hydroksy-16,16-dimetylestr-4-en-3-on med terapeutisk aktivitet.
CA978525A (en) Derivatives of 1,2-dihydroquinobenzoxa(or thia) zepine-3-one, oximes
CA1010039A (en) Process for the manufacture of s-triazinyl-monoisocyanates or s-triazinyl-diisocyanates
ZA738274B (en) Process for the manufacture of 9,10-seco-oestrane derivatives
IL46821A0 (en) New 1,2,4-benzotriazine derivatives,their production and their use for the control of microorganisms
CA1010897A (en) Process for the preparation of 3-acetamido-5-amino-2,4,6-triiodobenzoic acid
CA1034521A (en) PROCESS FOR THE PREPARATION OF 17-ACYL ESTERS OF 17.alpha.,21-DIHYDROXYSTEROIDS OF THE PREGNANE SERIES
CA1027973A (en) Process for the preparation of 1,2-dichloroethane
CA981697A (en) Process for the manufacture of 3,4-dichlorobutene-1
NL7413524A (nl) Werkwijze voor de bereiding van thiazolo(5,4-f)- chinoline-8-carbonzuurderivaten.
CA969175A (en) 6.alpha.,9.alpha.-DIFLUOROSTEROIDS OF THE PREGNANE SERIES AND PROCESSES FOR THEIR MANUFACTURE
CA1030448A (en) Blood control standard
GB1407381A (en) Process for the manufacture of 2,2-anhydro-1beta-d-arabino furanosyl-5-fluoroctosine
CA978524A (en) 3-amino-2,3-dihydroquinobenzox-a(or thia)-zepine derivatives
NL7412463A (nl) Werkwijze voor de bereiding van 1,2-dihydro-2- -oxo-4-methyl-7-aminochinoline alsmede van 1,2-dihydro-2-oxo-4-methyl-7-acetazijnzuur- -amidochinoline.
NL7414541A (nl) Werkwijze voor de bereiding van hart-glycoside- -derivaten, werkwijze voor de bereiding van therapeutische preparaten, alsmede de gevormde preparaten.
CA842819A (en) Process for the production of new sulphur compounds of 1,2-dithiol-3-ones and their use for the control of microorganisms
CA981698A (en) Process for the manufacture of 3,4-dichlorobutene-1